Hinge Health, Inc. (HNGE)
107.51
+3.55
(+3.41%)
USD |
NYSE |
Oct 20, 16:00
107.91
+0.40
(+0.37%)
Pre-Market: 07:25
Hinge Health Research and Development Expense (TTM) : 129.07M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 129.07M |
| March 31, 2026 | 374.98M |
| December 31, 2025 | 368.14M |
| September 30, 2025 | 357.75M |
| June 30, 2025 | 349.62M |
| March 31, 2025 | 94.58M |
| Date | Value |
|---|---|
| December 31, 2024 | 100.84M |
| September 30, 2024 | 107.05M |
| June 30, 2024 | 111.72M |
| March 31, 2024 | 114.60M |
| December 31, 2023 | 110.06M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median